Background
Methods
Patients
Imaging acquisition
Imaging analysis
Statistical analysis
Results
Patients
Characteristics | Value | Percentage (range) |
---|---|---|
Age (years) | 57.4 ± 12.1 | 33–78 |
Sex | ||
Male | 12 | 52.2% |
Female | 11 | 47.8% |
History of malignancy | ||
Breast cancer | 7 | 30.4% |
Lung cancer | 4 | 17.4% |
Colorectal cancer | 3 | 13.0% |
Ovarian tumor | 2 | 8.7% |
Osteosarcoma | 2 | 8.7% |
Gastric stromal tumor | 1 | 4.3% |
Endometrial cancer | 1 | 4.3% |
Thyroid cancer | 1 | 4.3% |
Malignant teratoma | 1 | 4.3% |
Hepatocellular cancinoma | 1 | 4.3% |
Primary treatment | ||
No treatment | 16 | 69.6% |
Surgery + chemotherapy +RT | 3 | 13.0% |
Surgery + chemotherapy | 4 | 17.4% |
Lesion sites | Primary | Metastasis | Total | Percentage |
---|---|---|---|---|
Liver | 1 | 11 | 12 | 30% |
Breast | 6 | 0 | 6 | 15% |
Lung | 2 | 2 | 5 | 12.5% |
Pleura | 0 | 3 | 3 | 7.5% |
Lymph node | 0 | 3 | 3 | 7.5% |
Peritoneum | 0 | 2 | 2 | 5% |
Subcutaneous soft tissues | 0 | 2 | 2 | 5% |
Ovary | 2 | 0 | 2 | 5% |
Chest wall | 0 | 1 | 1 | 2.5% |
Brain | 0 | 1 | 1 | 2.5% |
Uterus | 1 | 0 | 1 | 2.5% |
thyroid | 1 | 0 | 1 | 2.5% |
Mediastinum | 1 | 0 | 1 | 2.5% |
Total | 14 | 26 | 40 | 100% |
WBS and SPECT/CT findings
Pat. | Clinical diagnosis | Primary treatment | WBS | SPECT/CT finding | Final diagnosis | ||
---|---|---|---|---|---|---|---|
Localization | Intensity (n) | Localization | CA | ||||
1 | Gastric stromal tumor | NA | L. 7th posterior rib | H (1) | L. Lung | + | Lung cancer (adenocarcinoma) |
2 | Lung cancer | NA | R. Anterior chest wall | L (1) | R. Lung | + | Lung cancer (adenocarcinoma) |
3 | Lung cancer | Surgery + chemotherapy +RT | R. occipital bone | H (1) | R. Brain | + | Brain metastasis |
4 | Breast cancer | NA | R. Anterior chest wall | M (1) | R. Breast | + | Breast cancer |
5 | Breast cancer | NA | R. 3th posterior rib | M (1) | R. Breast | _ | Breast cancer |
6 | Breast cancer | NA | R. 5-6th posterior rib | H (1) | R. Breast | + | Breast cancer |
7 | Breast cancer | NA | R. Anterior chest wall | L (1) | R breast | + | Breast cancer |
8 | Breast cancer | Surgery + chemotherapy +RT | R.6th posterior rib | H (1) | R. anterior chest wall | _ | Recurrent breast cancer |
9 | Breast cancer | NA | L. Anterior chest wall | L (1) | L breast | _ | Breast cancer |
10 | Breast cancer | NA | R. Anterior chest wall | H (1) | R breast | + | Breast cancer |
11 | Rectal cancer | Surgery + chemotherapy | R. 4-5th posterior rib | M (1) | R. Lung | + | Lung metastasis |
12 | Colorectal cancer | Surgery + chemotherapy | R. Upper abdomen | L (4) | Liver | + | Liver metastasis |
13 | Rectal cancer | Surgery + chemotherapy | R. Upper abdomen | L (4) | Liver | + | Liver metastasis |
14 | Ovarian cancer | Surgery + chemotherapy | L. Pubic bone | H (1) | Lymph node | + | Lymph node metastasis |
15 | Ovarian cancer | NA | Abdominopelvic cavity | H (1) | Peritoneum | + | Peritoneal metastasis |
16 | Breast cancer | NA | L. Pelvic cavity | H (1) | Ovary | + | Ovarian thecoma |
17 | Osteosarcoma | NA | L. Supraclavicular region Multiple rib L. Upper abdomen Third lumbar vertebra | H (4) M (2) L (2) | L. Supraclavicular Lymph node R. Lung L. Upper peritoneum Subcutaneous soft tissues | + | Multiple metastasis |
18 | Osteosarcoma | NA | Multiple rib | H (2) | Mediastinal lymph node | + | Lymph node metastasis |
19 | Primary liver malignancy | NA | R. Upper abdomen | H (1) | Liver | + | HCC |
20 | Thyroid cancer | NA | Lower cervical vertebra | M (1) | Right thyroid | – | Medullary thyroid cancer |
21 | Uterine malignancy | NA | R. Sacroiliac joint | H (1) | Uterus | – | Endometrial cancer |
22 | Mediastinum tumor | NA | R. Anterior chest wall | H (1) | Mediastinum | + | Malignant teratoma |
23 | Lung cancer | Surgery + chemotherapy +RT | R. Upper abdomen | L (3) | Liver | _ | Liver metastasis |